These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3744942)

  • 1. Stable reduction product of misonidazole.
    Panicucci R; McClelland RA; Rauth AM
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1227-30. PubMed ID: 3744942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misonidazole-glutathione conjugates in CHO cells.
    Varghese AJ; Whitmore GF
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1341-5. PubMed ID: 6540764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misonidazole increases the toxicity of BCNU for hypoxic cells.
    Tannock I; Guttman P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):663-6. PubMed ID: 7107395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misonidazole neurotoxicity in mice decreased by administration with pyridoxine.
    Eifel PJ; Brown DM; Lee WW; Brown JM
    Int J Radiat Oncol Biol Phys; 1983 Oct; 9(10):1513-9. PubMed ID: 6629891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction of 2-nitroimidazole metabolites with guanine and possible biological consequences.
    Whitmore GF; Varghese AJ; Gulyas S
    IARC Sci Publ; 1986; (70):185-96. PubMed ID: 3793172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of misonidazole cytotoxicity by iron.
    Samuni A; Bump EA; Mitchell JB; Brown JM
    Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Jan; 49(1):77-83. PubMed ID: 3079744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased hypoxic toxicity and binding of misonidazole by low glucose concentration.
    Ling LL; Streffer C; Sutherland R
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1231-4. PubMed ID: 3744943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxic toxicity of misonidazole in a glucose-6-phosphate dehydrogenase deficient mutant Chinese hamster ovary cell line.
    de Groot H; Ling LL; Sutherland RM
    Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):1017-20. PubMed ID: 3053537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.
    Sasai K; Shibamoto Y; Takahashi M; Abe M; Wang J; Zhou L; Nishimoto S; Kagiya T
    Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials of radiosensitizers: what should we expect?
    Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):425-9. PubMed ID: 6231272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
    Mulcahy RT
    Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
    Horsman MR; Evans JW; Brown JM
    Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and excretion of [3H]misonidazole by hypoxic rat liver.
    Smith BR; Born JL
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1365-70. PubMed ID: 6469758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of glycolysis and hexose monophosphate pathway in the hypoxic toxicity of misonidazole.
    De Groot H; Ling LL; Sutherland RM
    Free Radic Res Commun; 1987; 3(1-5):93-8. PubMed ID: 3508447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
    Overgaard J
    Br J Cancer; 1980 Jan; 41(1):10-21. PubMed ID: 7362770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oxygen on misonidazole chemosensitization and cytotoxicity in vitro.
    Mulcahy RT
    Cancer Res; 1984 Oct; 44(10):4409-13. PubMed ID: 6467202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.
    Taylor YC; Rauth AM
    Br J Cancer; 1980 Jun; 41(6):892-900. PubMed ID: 7426314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor.
    Lehman CM; Stewart JR
    Radiat Res; 1983 Dec; 96(3):628-34. PubMed ID: 6657927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and radiosensitization of 4,5-dimethylmisonidazole, a ring-substituted analog of misonidazole.
    Born JL; Smith BR; Harper N; Koch CJ
    Biochem Pharmacol; 1992 Mar; 43(6):1337-44. PubMed ID: 1562284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
    Law MP; Hirst DG; Brown JM
    Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.